GFS
ABBV icon

GYL Financial Synergies’s AbbVie ABBV Stock Holding History

GYL Financial Synergies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.08M Sell
35,868
-1,233
-3% -$230K 0.53% 46
2024
Q2 		$6.36M Buy
37,101
+359
+1% +$59.5K 0.49% 51
2024
Q1 		$6.69M Buy
36,742
+2,627
+8% +$453K 0.52% 47
2023
Q4 		$5.29M Sell
34,115
-642
-2% -$93.6K 0.44% 57
2023
Q3 		$5.18M Sell
34,757
-315
-0.9% -$46.2K 0.5% 50
2023
Q2 		$4.73M Buy
35,072
+19,761
+129% +$2.9M 0.43% 55
2023
Q1 		$2.44M Buy
15,311
+4,942
+48% +$756K 0.29% 70
2022
Q4 		$1.68M Buy
10,369
+318
+3% +$48.8K 0.36% 44
2022
Q3 		$1.35M Buy
10,051
+72
+0.7% +$10.3K 0.37% 41
2022
Q2 		$1.53M Sell
9,979
-770
-7% -$118K 0.42% 36
2022
Q1 		$1.74M Sell
10,749
-2,540
-19% -$369K 0.42% 29
2021
Q4 		$1.8M Buy
13,289
+405
+3% +$47.8K 0.49% 35
2021
Q3 		$1.39M Buy
12,884
+189
+1% +$21.6K 0.71% 26
2021
Q2 		$1.43M Buy
12,695
+1,302
+11% +$147K 0.74% 24
2021
Q1 		$1.23M Sell
11,393
-456
-4% -$48.8K 0.68% 28
2020
Q4 		$1.27M Sell
11,849
-93
-0.8% -$8.94K 0.73% 28
2020
Q3 		$1.05M Buy
11,942
+146
+1% +$13.7K 0.69% 29
2020
Q2 		$1.16M Sell
11,796
-901
-7% -$79.3K 0.84% 26
2020
Q1 		$967K Buy
12,697
+92
+0.7% +$7.84K 0.62% 31
2019
Q4 		$1.12M Buy
12,605
+635
+5% +$52.7K 0.49% 40
2019
Q3 		$906K Buy
11,970
+393
+3% +$26.9K 0.45% 44
2019
Q2 		$842K Buy
11,577
+166
+1% +$13K 0.45% 45
2019
Q1 		$920K Sell
11,411
-104
-0.9% -$8.51K 0.52% 41
2018
Q4 		$1.06M Buy
+11,515
New +$1.01M 0.77% 23

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

GYL Financial Synergies's ABBV Position: Q3 2024 in Review

GYL Financial Synergies reduced its AbbVie (ABBV) stake by 3.3% in Q3 2024, selling an estimated $230K and leaving 35,868 shares worth $7.08M. The position accounts for 0.53% of the portfolio, ranked #46.

GYL Financial Synergies first reported a position in ABBV in Q4 2018 and has held it in 24 quarters since. 3,504 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • GYL Financial Synergies held 35,868 shares of AbbVie worth $7.08M as of Q3 2024.
  • GYL Financial Synergies sold 1,233 AbbVie shares in Q3 2024, an estimated $230K.
  • AbbVie made up 0.53% of GYL Financial Synergies's portfolio in Q3 2024, its #46 holding.
  • GYL Financial Synergies first reported a position in AbbVie in Q4 2018 and has held it in 24 quarters since.
  • 3,504 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on GYL Financial Synergies's 13F filing for Q3 2024, filed 7 Nov 2024.